Biological Sample Collection for Parkinson's (NCT06203106)
Enable new Parkinson treatment development
- Trial ID
- NCT06203106
- Official Title
- NYSCF Scientific Discovery Biobank
- Goal
- Enable new Parkinson treatment development
- Status
- RECRUITING
- Sponsor
- New York Stem Cell Foundation Research Institute
- Study Type
- OBSERVATIONAL
- Enrollment
- 10000 participants
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset, Batten Disease, Corticobasal Degeneration, Dementia, Frontotemporal Dementia, Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, INAD, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Macular Degeneration, Ovarian Cancer, Cervical Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer, PTSD, Post Traumatic Stress Disorder
- Interventions
- Biological Sample Collection
Summary For Families
The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
Locations
- New York Stem Cell Foundation Research Institute, New York, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Biological Sample Collection. The goal is to build a large, shared biobank of blood, saliva, skin, and transferred samples linked to medical data so researchers can speed up discovery of biomarkers and new treatments for Parkinson's and many other neurological and medical conditions. Participants provide samples that can be used to extract DNA, measure proteins, create induced pluripotent stem cell lines, and run lab studies to understand disease mechanisms or test experimental therapies. The study is open to people 30 days and older who have Parkinson's disease or other listed conditions, or who are healthy controls, with adults providing consent and people without decisional capacity allowed with assent plus a legally authorized representative consent. People who are wards of the state, who have certain bleeding or skin-healing problems relevant to sample collection, or who have AIDS with CD4 under 200 are excluded.
- Who can participate?
- Participants must be at least 30 Days.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 23 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Blood draw (minimally invasive); Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.